- Home
- Signaling Pathways
- Microbiology & Virology
- Antibiotic
- 5-hydroxypyrazine-2-carboxylic acid
- Home
- Lab Reagents
- Antibiotics
- 5-hydroxypyrazine-2-carboxylic acid
5-hydroxypyrazine-2-carboxylic acid
Physical Appearance | A solid |
Storage | Store at -20°C |
M.Wt | 140.1 |
Cas No. | 34604-60-9 |
Formula | C5H4N2O3 |
Solubility | insoluble in EtOH; ≥7 mg/mL in DMSO; ≥7.63 mg/mL in H2O |
Chemical Name | 5-hydroxypyrazine-2-carboxylic acid |
SDF | Download SDF |
Canonical SMILES | OC1=NC=C(C(O)=O)N=C1 |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Animal experiment [1]: | |
Animal models |
Sprague-Dawley female rats |
Dosage form |
50mg/kg,100mg/kg(p.o.) |
Application |
Quantitative analysis of PZA and its three major metabolites in 24-hour urine samples were performed by reversed-phase high-performance liquid chromatography. Caffeine (100mg/kg) and PZA (50mg/kg) administered simultaneously increase the excretion of the most soluble and least toxic PZA metabolite 5-hydroxypyrazine-2-carboxylic acid (from 66.18 +/- 10.87 to 94.56 + /-8.65μM / 24 h). This effect was even more pronounced when PZA was administered at 100 mg / kg: the excretion of 5-OH-PA was increased from 113.28 +/- 70 to 173.23 +/- 17.82 μM / 24 h. These results suggest that caffeine intake can affect PZA metabolism. |
Other notes |
Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal. |
References: [1]. Mehmedagic A, Verite P, Menager S, Tharasse C, Chabenat C, Andre D, Lafont O. Investigation of the effects of concomitant caffeine administration on the metabolic disposition of pyrazinamide in rats. Biopharm Drug Dispos. 2002 Jul;23(5):191-5. doi: 10.1002/bdd.305. PMID: 12116050. |
Quality Control & MSDS
- View current batch: